secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2026-07-01T20:15:31+00:00
Accession:  0001193125-26-292567
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio director Andrew Levin resigns; Breanna O'Reilly elected to board
--------------------------------------------------------------------------

- Andrew Levin resigned from the board effective June 29, 2026.
- Breanna O'Reilly, Ph.D., elected as director effective June 29, 2026.
- O'Reilly received option for 70,284 shares at $13.36, vesting over 3 years.
- O'Reilly to receive $40,000 annual cash retainer and annual equity grants.
- No family relationships or related-party transactions with O'Reilly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/0001193125-26-292567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/d61061d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-292567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer